2% Lidocaine Plus 0.5% Bupivacaine Versus 0.5% Bupivacaine in Brachial Block for Creation of Arteriovenous (AV) Fistula

Phase 4

• Conditions: Infraclavicular Brachial Plexus Block
• Interventions: Drug: Bupivacaine plus lidocaine; Drug: Bupivacaine 30 ml

• Registration Number: NCT00993746
• Lead Sponsor: Mahidol University

Brief Summary

Will the technique of adding lidocaine to bupivacaine fasten the onset of bupivacaine alone for infraclavicular brachial plexus block in end-stage renal disease (ESRD) patient?

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2009-09-27
• Status Verified: 2009-10
• Study Start: 2009-10
• Study First Submitted QC: 2009-10-09
• Study First Posted: 2009-10-12
• Last Update Submitted: 2010-05-14
• Last Update Posted: 2010-05-17
• Primary Completion: 2010-09
• Study Completion: 2011-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

• ESRD patient for AVF procedure
• age >17 year
• BMI 20-35 kg/m2
• communicable

Exclusion Criteria

• BMI > 35 kg/m2 BMI < 20 kg/m2 หรือ BW < 35 kg
• History of allergy to local anesthetic drugs
• Pre-operative neurological deficit, Neuromuscular disorder หรือ old CVA
• Psychiatric disorder
• Coagulation disorder
• Uncontrolled seizure
• Pregnant and lactating women

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Bupivacaine plus lidocaine	Bupivacaine plus lidocaine	Group 1: bupivacaine 20 ml plus lidocaine 10 ml
Bupivacaine alone	Bupivacaine 30 ml	Group 2: bupivacaine 30 ml

Primary Outcome Measures

Name	Time	Method
onset of sensory block	24 hour

Secondary Outcome Measures

Name	Time	Method
onset of motor block	24 hour

Trial Locations

Locations (1)

Department of anesthesiology Siriraj Hospital Mahidol University; 🇹🇭 Bangkok, Thailand